Novo Nordisk L (0QIU)

  • A brief financial summary of Novo Nordisk L as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Select Exchange

Symbol Exchange Currency
NOVOb Copenhagen DKK Real-time NOVOBc BATS Europe DKK Delayed NVO NYSE USD Real-time 0QIU London DKK Real-time NVON Mexico MXN Delayed NOVG Frankfurt EUR Delayed NOVG Xetra EUR Delayed NOVG Dusseldorf EUR Delayed NNO2 Vienna EUR Real-time
655.70 +1.85 (+0.28%)
Close DKK Disclaimer

0QIU Financial Summary

Novo Nordisk A/S reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was DKK 54,300 million compared to DKK 41,265 million a year ago. Net income was DKK 19,428 million compared to DKK 13,318 million a year ago. Basic earnings per share from continuing operations was DKK 4.325 compared to DKK 2.935 a year ago. Diluted earnings per share from continuing operations was DKK 4.315 compared to DKK 2.93 a year ago.For the six months, sales was DKK 107,667 million compared to DKK 83,296 million a year ago. Net income was DKK 39,242 million compared to DKK 27,528 million a year ago. Basic earnings per share from continuing operations was DKK 8.73 compared to DKK 6.055 a year ago. Diluted earnings per share from continuing operations was DKK 8.705 compared to DKK 6.04 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
0QIU Income Statement
0QIU
Gross margin TTM 84.35%
Operating margin TTM 43.2%
Net Profit margin TTM 33.4%
Return on Investment TTM 64.41%
Total Revenue
Net Income
Title
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Total Revenue 54,300 53,367 48,092 45,566
Gross Profit 46,444 45,185 39,830 38,366
Operating Income 23,888 25,007 17,898 20,184
Net Income 19,428 19,814 13,592 14,405

Customize

Clear All
0Selected
Please try another search
0QIU Balance Sheet
0QIU
Quick Ratio MRQ 0.62
Current Ratio MRQ 0.88
LT Debt to Equity MRQ 21.46%
Total Debt to Equity MRQ 28.41%
Total Assets
Total Liabilities
Title
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Total Assets 280,753 250,025 241,257 242,836
Total Liabilities 190,280 170,151 157,771 166,156
Total Equity 90,473 79,874 83,486 76,680

Customize

Clear All
0Selected
Please try another search
0QIU Cash Flow Statement
0QIU
Cash Flow/Share TTM 20.02
Revenue/Share TTM 44.91
Operating Cash Flow 18.25%
Cash
Net Change in Cash
Title
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Cash From Operating Activities 28,577 29,814 7,101 24,239
Cash From Investing Activities -9,285 -6,647 -13,850 -4,961
Cash From Financing Activities -12,589 -20,621 -7,668 -14,563
Net Change in Cash 6,638 2,283 -15,261 5,158

Customize

Clear All
0Selected
Please try another search

* In Millions of DKK (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles